← Open Payments lookup

CARMENCITA LANEZ: Open Payments

NPI 1770643959 · HOPELAWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,690 in 181 payments from 15 companies in 2025. Trend: 2023 $12,374 · 2024 $8,053 · 2025 $5,690

Speaker / faculty: $3,150Food & beverage: $2,540
CompanyPaymentsAmount
ABBVIE INC.32$3,512
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)38$513
Neurocrine BioSciences, Inc.25$416
Otsuka America Pharmaceutical, Inc.14$213
Lundbeck LLC17$199
Alkermes, Inc.13$197
Axsome Therapeutics, Inc.12$158
Tris Pharma Inc7$112
Supernus Pharmaceuticals, Inc.6$99
E.R. Squibb & Sons, L.L.C.5$85

Products named: VRAYLAR, CAPLYTA, INGREZZA, REXULTI, Auvelity, ABILIFY MAINTENA, ARISTADA, Dyanavel XR.

Industry payments across NJ — which companies pay providers there.